Menu
Fechar
hrs4r
 I want to donate

The research group for descriptive epidemiology, genetics, and prevention of cancer is a multidisciplinary group that includes epidemiologists, statisticians, oncologists, radiotherapists, a physiotherapist, a dermatologist; a biologist, a nurse, and medical documentalists, biologist. The main focus of the group is cancer epidemiology (descriptive and analytical), cancer prevention, and genetics.

Main lines of research

Descriptive and analytical epidemiology of cancer.

Strategic objectives
  1. Descriptive and analytical epidemiology of cancer
  • Registering cancer based on population for the province of Girona (with national and international collaborations).
    • Incidence and populational prevalence of cancer, projections of the incidence of cancer
    • Populational survival of cancer (international collaborations: EUROCARE and CONCORD studies).
  • Study of genetic and molecular factors in the prognosis of breast cancer and haematological tumours.
  • Study of genetic and environmental risk factors in breast cancer and chronic lymphocytic leukaemia.
  1. Cancer prevention
  • Evaluation of the organized breast cancer screening program
  • Benefits and adverse effects of breast cancer detection: Method to improve the measurement of early detection results.
  • Evaluation of the interval rate of cancer and its determining factors in the early detection program of breast cancer in the Girona health region.
  • Evaluation of the timely detection program for cervical cancer.
  • Determination of the sensitivity and specificity of cervical cytology.
  • Evaluation of the effectiveness of vaccination against the human papilloma virus.
  1. Genetics (The genetic epidemiology of cancer)
  • Evaluation of the risk of developing cancer.
  • Study of genetic risk factors for cancer.
  • Genetic susceptibility to cancer.
Publications
Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O'Brian DK, Saint-Jacques N, Coleman MP, Allemani C, CONCORD Working Group

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)

Neuro-Oncology, 2023, 25, 580-592 dx.doi.org/10.1093/neuonc/noac217
Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM

Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 dx.doi.org/10.3390/ijerph20010405
Cortellini A, Tabernero J, Mukherjee U, Salazar R, Sureda A, Maluquer C, Ferrante D, Bower M, Sharkey R, Mirallas O, Plaja A, Cucurull M, Mesia R, Dalla Pria A, Newsom-Davis T, Van Hemelrijck M, Sita-Lumsden A, Apthorp E, Vincenzi B, Di Fazio GR, Tonini G, Pantano F, Bertuzzi A, Rossi S, Brunet J, Lambertini M, Pedrazzoli P, Biello F, D'Avanzo F, Lee AJX, Shawe-Taylor M, Rogers L, Murphy C, Cooper L, Andaleeb R, Khalique S, Bawany S, Ahmed S, Carmona-García MC, Fort-Culillas R, Liñan R, Zoratto F, Rizzo G, Perachino M, Doonga K, Gaidano G, Bruna R, Patriarca A, Martinez-Vila C, Pérez Criado I, Giusti R, Mazzoni F, Antonuzzo L, Santoro A, Parisi A, Queirolo P, Aujayeb A, Rimassa L, Diamantis N, Bertulli R, Fulgenzi CAM, D'Alessio A, Ruiz-Camps I, Saoudi-Gonzalez N, Garcia Illescas D, Medina I, Fox L, Gennari A, Aguilar-Company J, Pinato DJ

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.

LANCET ONCOLOGY, 2023, 24, 335-346 dx.doi.org/10.1016/S1470-2045(23)00056-6
Hernández-Rubio A, Sanvisens A, Barbier-Torres L, Blanes R, Miquel L, Torrens M, Rubio G, Bolao F, Zuluaga P, Fuster D, Rodríguez de Fonseca F, Farré M, Muga R

Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder.

DRUG AND ALCOHOL DEPENDENCE, 2023, 245, 109822-109822 dx.doi.org/10.1016/j.drugalcdep.2023.109822
Giusti F, Martos C, Trama A, Bettio M, Sanvisens A, Audisio R, Arndt V, Francisci S, Dochez C, Ribes J, Fernández LP, Gavin A, Gatta G, Marcos-Gragera R, Lievens Y, Allemani C, De Angelis R, Visser O, Van Eycken L

Cancer treatment data available in European cancer registries: Where are we and where are we going?

Frontiers in oncology, 2023, 13, 1109978-1109978 dx.doi.org/10.3389/fonc.2023.1109978
Marruecos-Querol J, Rubió-Casadevall J, Lozano A, Buxó M, Puigdemont M, Linares I, Planas I, Vayreda J, Cirauqui B, Taberna M, Quiroga V, Tobed M, Borés A, Recalde S, Saigi M, Felip E, Eraso A, Mesía R

Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25, 2384-2392 dx.doi.org/10.1007/s12094-023-03121-9
Martínez-Bosch N, Vilariño N, Alameda F, Mojal S, Arumí-Uria M, Carrato C, Aldecoa I, Ribalta T, Vidal N, Bellosillo B, Menéndez S, Del Barco S, Gallego O, Pineda E, López-Martos R, Hernández A, Mesia C, Esteve-Codina A, de la Iglesia N, Balañá C, Martínez-García M, Navarro P

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.

Cells, 2023, 12 dx.doi.org/10.3390/cells12060843
Auñón C, Sanvisens A, Turon E, Vidal-Vila A, Puigdemont M, Osca-Gelis G, Eraso A, Marcos-Gragera R

Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).

CANCER MEDICINE, 2023, 12, 12343-12353 dx.doi.org/10.1002/cam4.5935
Cabrera-Serrano AJ, Sánchez-Maldonado JM, Ter Horst R, Macauda A, García-Martín P, Benavente Y, Landi S, Clay-Gilmour A, Niazi Y, Espinet B, Rodríguez-Sevilla JJ, Pérez EM, Maffei R, Blanco G, Giaccherini M, Cerhan JR, Marasca R, López-Nevot MÁ, Chen-Liang T, Thomsen H, Gámez I, Campa D, Moreno V, de Sanjosé S, Marcos-Gragera R, García-Álvarez M, Dierssen-Sotos T, Jerez A, Butrym A, Norman AD, Luppi M, Slager SL, Hemminki K, Li Y, Berndt SI, Casabonne D, Alcoceba M, Puiggros A, Netea MG, Försti A, Canzian F, Sainz J

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms24098005
Farré X, Mousavi SM, Marcos-Gragera R, Malaker K

A Global Perspective on the Controversy of Gleason Score 6 Prostate Cancer Reporting: The Potential Role of Population-Based Cancer Registries.

Jco Global Oncology, 2023, 9 dx.doi.org/10.1200/GO.22.00427
Competitive projects
Descriptive epidemiology, genetics and cancer prevention

Incidencia, tendencia y superivivencia neta de las neoplasias linfoides en Espala (1993-último año disponible)

Codi oficial: Projecte IJC - Dr. Rafael Marcos-Gragera Start date:01/01/2021 Data fi: 31/12/2024 Investigador/a principal: RAFEL MARCOS GRAGERA Organisme finançador: FUNDACIÓ INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS Ajuda: 12,500 €
Descriptive epidemiology, genetics and cancer prevention

European Linkage of Initiative from Science to Action in Health

Codi oficial: EU4H-2022-PJ-12 Start date:01/01/2024 Data fi: 31/12/2026 Investigador/a principal: RAFEL MARCOS GRAGERA Organisme finançador: EUROPEAN COMISSION Ajuda: 100,498.68 €
Transfer
Guies clíniques

- Adherence to the 2018 WCRF/AICR cancer prevention guidelines and chronic lymphocytic leukemia in the MCC-Spain study.

- A Poveda; V Martinez; C Serrano; I Sevilla; M J Lecumberri; RD de Beveridge; A Estival; D Vicente; J Rubió; J Martin-Broto J. SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016). Clinical Translational Oncology. Dec;18(12):1221-1228

- Gavin A,Rous B, Marcos-Gragera R, Middleton R, Steliarova-Foucher E, Maynadie M, Zanetti R, Visser O; European Network of Cancer Registries. “Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses”. European Journal of Cancer. 2015 Jun;51(9):1109-22. doi: 10.1016/j.ejca.2014.02.008

- Luque R,Benavides M,Del Barco S,Egaña L,García J,Martínez M,Pérez P,Pineda E,Sepúlveda JM,Vieito M. SEOM clinical guideline for management of adult medulloblastoma (2020). Clin Transl Oncol. 2021. 23(5):p. 940-947. IF:3,405. (Q3).

Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

 menu